Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 54.900M	--
Mar 6, 2025	2024/Q4	-- / 60.000M	--
Nov 8, 2024	2024/Q3	54.268M / 51.433M	--
Aug 8, 2024	2024/Q2	48.065M / 45.811M	--
May 9, 2024	2024/Q1	40.638M / 41.815M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 54.900M--

Mar 6, 20252024/Q4-- / 60.000M--

Nov 8, 20242024/Q354.268M / 51.433M--

Aug 8, 20242024/Q248.065M / 45.811M--

May 9, 20242024/Q140.638M / 41.815M--

Unlock Free Earnings Estimates

Open Account

Xeris Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 8, 2024 16:05 ET

Xeris Pharmaceuticals | 8-K: XERIS BIOPHARMA REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS

Nov 8, 2024 07:15 ET

Xeris Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 8, 2024 16:44 ET

Xeris Pharmaceuticals | 8-K: XERIS XERIS BIOPHARMA REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS

Aug 8, 2024 07:19 ET

Symbol Mini Chart % Chg

Unlock the Full List

Analysis

Updated: Jan 21, 2025

Strong Buy

No Data